RxDoctor Payments Data

Brett Kockentiet, MD

MOHS-Micrographic Surgery · Dublin, OHNPI 1306056171

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Galderma Laboratories, L.p. at 37.6% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in OH, where the typical reported total is $1,196.

$1,196in general payments, 2019–2025

Across 33 payments — averaging $36.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$450
  • AbbVie$192
  • Sun Pharmaceutical Industries Inc.$144
  • Johnson & Johnson$131
  • Regeneron Healthcare Solutions, Inc.$122
  • Pfizer$64
  • plus $93 from 4 others

What the payments were for

  • Speaking & faculty fees$45038%
  • Food & beverage$71560%
  • Education$313%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,196 in reported general payments places this provider in the 50th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$633,137
Medicare patients
818
Services billed
4,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clindamycin Phosphate29$1,987
Fluorouracil28$1,951
Clobetasol Propionate46$1,690
Betamethasone Dipropionate32$1,626
Mupirocin256$1,473
Ketoconazole66$1,133
Triamcinolone Acetonide85$1,131
Azathioprine12$829
Fluocinonide15$753
Pentoxifylline15$751
MethotrexateMethotrexate Sodium47$658
Hydroxychloroquine Sulfate13$582
Imiquimod23$542
Doxycycline Hyclate30$521
Mometasone Furoate24$416

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →